MBX Capital
New York, New York · Invests in US; North America · Website
Check size
🔒 $•• – $••Thesis
Deep health emerges at the convergence of advances in biology, chemistry, AI/ML, robotics, and clinical medicine. We back visionary founders addressing root causes of chronic disease across three domains: biology within us (biotech platforms), environment around us (environmental/chemical health), and systems that care for us (healthcare delivery innovation).
Likely not a fit for
No incremental healthcare automation, pure administrative software, symptom management without root cause treatment, or virtualized legacy care models.
How they invest
- Lead or follow
- Usually leads
- Typical decision
- ~2 weeks
- Warm intro
- Not required
- Involvement
- Takes a board seat
- Fund status
- Actively deploying
- Assets under mgmt
- $100M
- Decision process
- Partnership vote
Partners & team
2 contacts on file
LinkedIn profile
Sign up free to unlock contact →Portfolio
Persist AI is focused on AI-driven drug discovery and formulation development, utilizing robotics to enhance the speed and efficiency of creating drug formulations.
Enoda is a synthetic biology company focused on transforming cells into disease-fighting machines through innovative cell therapies. They utilize molecular tools and high-throughput screening to engineer optimal cell types for various therapeutic indications.
Juniper Genomics is shaping a better future for aspiring parents by enabling a faster, more successful IVF journey through advanced genetic testing.
Tidal Vision specializes in advanced biomolecular solutions using chitosan to address significant environmental challenges in water treatment, agriculture, and material science.
Junction Health partners with Community Health Centers to improve access to care and thrive financially by building and operating on-site infusion centers.
Examol is focused on transforming drug discovery through computational methods, developing software that provides insights at the molecular level.
Forum was an online platform for consumer peer support groups, facilitating connections among individuals seeking support.
Macro Trials is dedicated to optimizing the landscape of clinical research, fostering innovation and collaboration to elevate patient care, and empowering diverse communities throughout their journey to better health. They partner with pharmaceutical companies, biotech firms, and clinicians to enhance access for diverse patient populations while navigating the complexities of trials with a technology-forward approach.
Arine focuses relentlessly on improving health outcomes through medication optimization, leveraging AI to provide tailored medication recommendations and interventions for health plans and providers.
Eva Tech is a digital radiology service provider offering business context, study references, and modernization strategies.
OFFOR Health is a mission-driven organization dedicated to improving healthcare access for underserved populations. We are committed to transforming healthcare delivery and ensuring every community receives the care they deserve.
Dezy Dental Care offers a wide range of dental treatments including aligners, implants, root canals, and more, with a network of expert dentists across multiple cities in India.
Recent activity
- Apr 2026
Keebler Health
Series A · Participant
- Jan 2026
Think Bioscience
Series A · Participant
- Nov 2025
Persist AI
Seed · Lead
- Nov 2025
Enoda Cellworks
Seed · Lead
- Nov 2025
Juniper
Seed · Lead
- May 2025
Persist AI
Series A · Participant
- May 2025
CND Life Sciences
Series A · Participant
- May 2025
Vivodyne
Series A · Participant
MBX Capital in the news
YourStory.com
Dognosis is training dogs and AI to detect cancer from a breath sample
1 month ago
Fierce Healthcare
Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
4 months ago
The SaaS News
Keebler Health Secures $16M Series A
4 months ago
Axios
Anchorage Digital eyes new round and GTCR's sports bet
7 months ago
BioSpace
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
7 months ago
The Business Journals
Startups to Watch: Persist AI looks to cut drug development time
7 months ago
thepharmaletter.com
MBX Capital’s fund for early-stage startups passes $100 million
8 months ago
citybiz
MBX Capital Launches $100M to Support Biotech Startups Addressing the Root Causes of Modern Disease
8 months ago
MedCity News
Investors Share How Early Stage Healthcare Startups Are Using AI
Jun 2025
MobiHealthNews
Persist AI secures $12M Series A funding, unveils Cloud Lab platform
May 2025
The American Bazaar
Persist AI raises $12 million to fix drug formulation
May 2025
The Business Journals
AI robotic drug development company Persist AI raises $12 million
May 2025
MedCity News
Get a Snapshot of the Early Stage Life Science Startup Landscape
May 2025
Oman Observer
Oman’s IDO invests in US biotech startup Tidal Vision
Feb 2025
AlleyWatch
The AlleyWatch Startup Daily Funding Report: 11/8/2023
Nov 2023
citybiz
Contraline, Developer of Long-Term Male Contraceptive, Raises $7.2 Million in Series A Round
Nov 2022
Newswire.com
OFFOR Health Completes Series A Round With Additional $9 Million Led by AXA Venture Partners (AVP)
Apr 2022
The Economic Times
Dentalcare startup Smiles raises $23 million from Alpha Wave, Sequoia India
Jan 2022
YourStory.com
[Funding alert] Dental care startup Smiles.ai raises $23M in Series A investment
Jan 2022
Femtech Insider
Contraline Raises a $10.7M Series A to Transition ADAM, its "Male Contraceptive", into Clinical Trials
Oct 2021
citybiz
Contraline Closes $10.7 Million Series A
Oct 2021
Business Wire
Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company
Oct 2021
The Globe and Mail
Out of the lab, into the marketplace: How one of Canada’s most celebrated scientists, Molly Shoichet, is bringing her key discovery to market
Feb 2021
Similar firms
Digital health venture capital firm focused on companies enabling new care delivery models or more efficient therapeutic development.
Healthcare-only platform spanning seed through IPO and beyond via public, private and credit/royalty arms; acts as a biotech IPO accelerator and validation, aiding NASDAQ/HKEX listings and confidential financings.
NYC-based healthtech VC investing across medical technologies and digital health.
Invests in disruptive, technology-focused startups; established in 1999.
Integrated venture, nonprofit platform, and research arm offering health-only expertise across human, health tech, and animal health, plus an animal-health franchise with Mars and links to ARPA-H initiatives.
Research briefRead more
Add MBX Capital to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up